Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (346)

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Automated procedure to detect subtle motor alterations in the balance beam test in a mouse model of early Parkinson’s disease

    Scientific Reports, Vol. 14, Núm. 1

  3. Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson’s disease: a systematic review

    Frontiers in Nutrition, Vol. 11

  4. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

  5. Machine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Disease

    Applied Sciences (Switzerland), Vol. 14, Núm. 18

  6. Medication impact on oral health in schizophrenia

    Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 29, Núm. 1, pp. e51-e57

  7. Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Biomedicines, Vol. 12, Núm. 7

  8. Predicting Parkinson’s Disease Progression: Analyzing Prodromal Stages Through Machine Learning

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  9. Prognostic factors for falls in Parkinson’s disease: a systematic review

    Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406

  10. Reactive antibodies against brain antigens as serological biomarkers of neurodegenerative diseases

    Advanced Neurology, Vol. 3, Núm. 1

  11. Retraction note: Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood–Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain (Molecular Neurobiology, (2015), 52, 2, (1043-1053), 10.1007/s12035-015-9254-7)

    Molecular Neurobiology

  12. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  13. Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations

    Frontiers in Psychology, Vol. 15

2023

  1. Abordaje multidisciplinar y difusión social de un problema sanitario

    Revista de innovación y buenas prácticas docentes, Vol. 12, Núm. 2, pp. 13-25

  2. Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685

  3. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  4. Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles

    Neurochemical Research, Vol. 48, Núm. 6, pp. 1864-1888

  5. Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma

    Advances in neurobiology, Vol. 32, pp. 195-229

  6. Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury

    International Review of Neurobiology (Academic Press Inc.), pp. 145-185

  7. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury

    Advances in Neurobiology (Springer), pp. 97-138